Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)	Series E Warrants [Member] Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	Series E Warrants [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Series E Warrants [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Series E Warrants [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Series E Warrants [Member] Preferred Stock [Member]	Series E Warrants [Member] Common Stock [Member]	Series E Warrants [Member] Additional Paid-in Capital [Member]	Series E Warrants [Member] Retained Earnings [Member]	Series E Warrants [Member]	Re-priced Warrants [Member] Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	Re-priced Warrants [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Re-priced Warrants [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Re-priced Warrants [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Re-priced Warrants [Member] Preferred Stock [Member]	Re-priced Warrants [Member] Common Stock [Member]	Re-priced Warrants [Member] Additional Paid-in Capital [Member]	Re-priced Warrants [Member] Retained Earnings [Member]	Re-priced Warrants [Member]	Warrants Issued to CEO [Member] Preferred Stock [Member]	Warrants Issued to CEO [Member] Common Stock [Member]	Warrants Issued to CEO [Member] Additional Paid-in Capital [Member]	Warrants Issued to CEO [Member] Retained Earnings [Member]	Warrants Issued to CEO [Member]	Warrants Issued to Helomics' Investors [Member] Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	Warrants Issued to Helomics' Investors [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Warrants Issued to Helomics' Investors [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Warrants Issued to Helomics' Investors [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Warrants Issued to Helomics' Investors [Member] Preferred Stock [Member]	Warrants Issued to Helomics' Investors [Member] Common Stock [Member]	Warrants Issued to Helomics' Investors [Member] Additional Paid-in Capital [Member]	Warrants Issued to Helomics' Investors [Member] Retained Earnings [Member]	Warrants Issued to Helomics' Investors [Member]	Warrants Held by Noteholders [Member] Preferred Stock [Member]	Warrants Held by Noteholders [Member] Common Stock [Member]	Warrants Held by Noteholders [Member] Additional Paid-in Capital [Member]	Warrants Held by Noteholders [Member] Retained Earnings [Member]	Warrants Held by Noteholders [Member]	Private Placement [Member] Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	Private Placement [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Private Placement [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Private Placement [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Private Placement [Member] Preferred Stock [Member]	Private Placement [Member] Common Stock [Member]	Private Placement [Member] Additional Paid-in Capital [Member]	Private Placement [Member] Retained Earnings [Member]	Private Placement [Member]	Over-Allotment Option [Member] Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	Over-Allotment Option [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Over-Allotment Option [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Over-Allotment Option [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Over-Allotment Option [Member] Preferred Stock [Member]	Over-Allotment Option [Member] Common Stock [Member]	Over-Allotment Option [Member] Additional Paid-in Capital [Member]	Over-Allotment Option [Member] Retained Earnings [Member]	Over-Allotment Option [Member]	S-3 Public Offering [Member] Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	S-3 Public Offering [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	S-3 Public Offering [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	S-3 Public Offering [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	S-3 Public Offering [Member] Preferred Stock [Member]	S-3 Public Offering [Member] Common Stock [Member]	S-3 Public Offering [Member] Additional Paid-in Capital [Member]	S-3 Public Offering [Member] Retained Earnings [Member]	S-3 Public Offering [Member]	Helomics Acquisition, Inc. [Member] Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	Helomics Acquisition, Inc. [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Helomics Acquisition, Inc. [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Helomics Acquisition, Inc. [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Helomics Acquisition, Inc. [Member] Preferred Stock [Member]	Helomics Acquisition, Inc. [Member] Common Stock [Member]	Helomics Acquisition, Inc. [Member] Additional Paid-in Capital [Member]	Helomics Acquisition, Inc. [Member] Retained Earnings [Member]	Helomics Acquisition, Inc. [Member]	Chief Executive Officer [Member] Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	Chief Executive Officer [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Chief Executive Officer [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Chief Executive Officer [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Chief Executive Officer [Member] Preferred Stock [Member]	Chief Executive Officer [Member] Common Stock [Member]	Chief Executive Officer [Member] Additional Paid-in Capital [Member]	Chief Executive Officer [Member] Retained Earnings [Member]	Chief Executive Officer [Member]	Shares Issued Pursuant to Note Conversions Bridge Loan [Member] Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	Shares Issued Pursuant to Note Conversions Bridge Loan [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Shares Issued Pursuant to Note Conversions Bridge Loan [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Shares Issued Pursuant to Note Conversions Bridge Loan [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Shares Issued Pursuant to Note Conversions Bridge Loan [Member] Preferred Stock [Member]	Shares Issued Pursuant to Note Conversions Bridge Loan [Member] Common Stock [Member]	Shares Issued Pursuant to Note Conversions Bridge Loan [Member] Additional Paid-in Capital [Member]	Shares Issued Pursuant to Note Conversions Bridge Loan [Member] Retained Earnings [Member]	Shares Issued Pursuant to Note Conversions Bridge Loan [Member]	Investment Banker [Member] Preferred Stock [Member]	Investment Banker [Member] Common Stock [Member]	Investment Banker [Member] Additional Paid-in Capital [Member]	Investment Banker [Member] Retained Earnings [Member]	Investment Banker [Member]	Preferred Stock [Member] Series C Convertible Preferred Stock [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2017																																																																																																					$ 7,271	$ 69,432	$ 57,380,256	$ (54,765,045)	$ 2,691,913
Balance (in shares) at Dec. 31, 2017																																																																																																	647,819	79,246				6,943,283
Warrant exercises						$ 888	$ 87,948		$ 88,836						$ 2,523	$ 249,810		$ 252,333
Warrant exercises (in shares)						88,836									252,333
Vesting Expense																																																																																																							460,368		460,368
Net income (loss)																																																																																																								(4,133,432)	(4,133,432)
Stock issued for Helomics acquisition																																																																						$ 11,000	$ 1,031,250		$ 1,042,250
Stock issued for Helomics acquisition (in shares)																																																																						1,100,000
Preferred conversion to common shares pursuant to private placement agreement																																										$ (6,479)	$ 5,897	$ 582																																																													(6,479)
Preferred conversion to common shares pursuant to private placement agreement (in shares)																																						(647,819)					589,747
Shares issued pursuant to S-3 public offering																																																				$ 2,153	$ 202,268	$ 1	$ 204,422																																															$ 29,000	2,726,087		2,755,087
Shares issued pursuant to S-3 public offering (in shares)																																																				215,247																																																		2,900,000
Balance at Jun. 30, 2018																																																																																																					792	$ 120,893	62,138,569	(58,898,476)	3,361,778
Balance (in shares) at Jun. 30, 2018																																																																																																		79,246				12,089,446
Balance at Mar. 31, 2018																																																																																																					792	$ 118,040	61,622,067	(56,525,066)	5,215,833
Balance (in shares) at Mar. 31, 2018																																																																																																		79,246				11,804,073
Warrant exercises						$ 330	$ 32,710		$ 33,040						$ 2,523	$ 249,810		$ 252,333
Warrant exercises (in shares)						33,040									252,333
Vesting Expense																																																																																																							233,982		233,982
Net income (loss)																																																																																																								(2,373,410)	(2,373,410)
Balance at Jun. 30, 2018																																																																																																					792	$ 120,893	62,138,569	(58,898,476)	3,361,778
Balance (in shares) at Jun. 30, 2018																																																																																																		79,246				12,089,446
Balance at Dec. 31, 2018																																																																																																					792	$ 140,917	63,019,708	(63,107,945)	53,472
Balance (in shares) at Dec. 31, 2018																																																																																																		79,246				14,091,748
Warrant exercises																																																																																													$ 5,786			$ 5,786
Warrant exercises (in shares)																																																																																													578,560
Vesting Expense																																																																																																							1,644,220		1,644,220
Net income (loss)																																																																																																								(1,828,080)	(1,828,080)
Shares issued pursuant to note conversions																																																																																								$ 5,586	$ 232,987		$ 238,573
Shares issued pursuant to note conversions (in shares)																																																																																								558,588
Issuance of warrants																					$ 341,608		$ 341,608							$ 6,261,591		$ 6,261,591			$ 117,241		$ 117,241
Stock issued for Helomics acquisition																																																																																																					35,000	$ 40,000	5,537,250		5,612,250
Stock issued for Helomics acquisition (in shares)																																																																																																			3,500,000			4,000,000
Value of shares to extinguish debt																																																																																																						$ 86,373	6,376,936		6,463,309
Stock issued to extinguish debt as part of Helomics purchase consideration (in shares)
Issuance of Series E Preferred shares																																										$ 1		$ 743,559		$ 743,560
Issuance of Series E Preferred shares (in shares)																																									84
Preferred conversion to common shares pursuant to private placement agreement
Shares issued pursuant to S-3 public offering																																																													$ 28,638	$ 2,401,071		$ 2,429,709															$ 781	$ 49,219		$ 50,000
Shares issued pursuant to S-3 public offering (in shares)																																																													2,863,750																		78,125
Shares issued in forbearance agreement																																																																																																						$ 1,666	156,683		158,349
Shares issued in forbearance agreement (in shares)																																																																																																						166,667
Balance at Jun. 30, 2019																																																																																																					35,793	$ 309,747	86,882,073	(64,936,025)	22,291,588
Balance (in shares) at Jun. 30, 2019																																																																																																		79,246	3,500,000	84		30,974,761
Balance at Mar. 31, 2019																																																																																																					792	$ 173,601	66,296,741	(66,401,129)	70,005
Balance (in shares) at Mar. 31, 2019																																																																																																		79,246				17,360,144
Warrant exercises																																																																																																						$ 5,786			5,786
Warrant exercises (in shares)																																																																																																						578,560
Vesting Expense																																																																																																							1,380,620		1,380,620
Net income (loss)																																																																																																								1,465,104	1,465,104
Shares issued pursuant to note conversions																																																																																																						$ 3,987	144,584		148,571
Shares issued pursuant to note conversions (in shares)																																																																																																						398,734
Issuance of warrants																					$ 23,550		$ 23,550							$ 6,261,591		$ 6,261,591			$ 117,241		$ 117,241
Stock issued for Helomics acquisition																																																																																																					35,000	$ 40,000	5,537,250		5,612,250
Stock issued for Helomics acquisition (in shares)																																																																																																			3,500,000			4,000,000
Value of shares to extinguish debt																																																																																																						$ 86,373	6,376,936		6,463,309
Stock issued to extinguish debt as part of Helomics purchase consideration (in shares)																																																																																																						8,637,323
Issuance of Series E Preferred shares																																																																																																					1		743,559		743,560
Issuance of Series E Preferred shares (in shares)																																																																																																				84
Balance at Jun. 30, 2019																																																																																																					$ 35,793	$ 309,747	$ 86,882,073	$ (64,936,025)	$ 22,291,588
Balance (in shares) at Jun. 30, 2019																																																																																																		79,246	3,500,000	84		30,974,761